Improved decision making in intermediate-risk prostate cancer: a multicenter study on pathologic and oncologic outcomes after radical prostatectomy.
Jean Baptiste BeauvalGuillaume PloussardBastien CabarrouMathieu RoumiguiéAdil OuzzaneJérome GasAnnabelle GoujonGautier MarcqRomain MathieuSébastien VincendeauXavier CathelineauPierre Mongiat-ArtusLaurent SalomonMichel SouliéArnaud MéjeanAlexandre de La TailleMorgan RouprêtFrançois Rozetnull nullPublished in: World journal of urology (2016)
This study highlights the heterogeneity of NCCN intermediate-risk patients and validates (in a large RP cohort) the previously proposed subclassification for this group. This classification can significantly predict both pathologic and oncologic outcomes. This easy-to-use stratification could help physicians' decision making. Prospective study and new tools as genomic tests and novel molecular-based approaches can improve this stratification in the future for patient counseling.
Keyphrases
- radical prostatectomy
- prostate cancer
- end stage renal disease
- decision making
- neoadjuvant chemotherapy
- ejection fraction
- newly diagnosed
- chronic kidney disease
- primary care
- locally advanced
- rectal cancer
- deep learning
- peritoneal dialysis
- copy number
- type diabetes
- metabolic syndrome
- hepatitis c virus
- dna methylation
- radiation therapy
- glycemic control